DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Devices Market (By Applications, Products, End Users, Regions), Impact of COVID-19, Major Deals, Trends, Key Players Analysis, Recent Developments – Forecast to 2027” report has been added to ResearchAndM…
Author: Business Wire
DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product Line
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the launch of Moisture Re…
North American Eyewear Market, by Product Type, Distribution Channel, End User and Region to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Eyewear Market, by Product Type, by Distribution Channel, by End User, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering. …
OPTRACT法 – ドナー角膜や細胞の効率的な輸送技術と無重力環境下での細胞保存による宇宙時代のアンチエイジング研究
東京–(BUSINESS WIRE)–（ビジネスワイヤ） — 日本の科学者が開発した効率的なヒトドナー角膜輸送法が、移植による視力回復を待つ何百万人もの患者を救うことができるかもしれません。OPTRACT法とは、病院とラボの間で輸送される細胞や組織をよりよい状態で保存する方法です。ヒトドナー角膜の他、ヒト口腔粘膜や軟骨でもこの方法を用いた研究が行われており、軟骨では老化の逆転ができることがわかっています。また、微小重力の環境下での免疫細胞の機能強化について日本の特許を取得しています。これらは、…
Global Bionic Eye (Implant v/s External) Markets Analysis, Company Forecast & Opportunities, 2016-2020 & 2021-2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Bionic Eye Market, By Type (Implant v/s External), By Technology (Electronic v/s Mechanical), By End User (Hospitals, Ophthalmic Clinics, Others), By Region, Company Forecast & Opportunities” report has been add…
Aldeyra Therapeutics Initiates Phase 2 Clinical Trial of ADX-2191 for the Treatment of Retinitis Pigmentosa
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that it has initiated a Phase…
Global Pseudoxanthoma Elasticum Market Insight, Epidemiology and Market Forecasts, 2019-2021 & 2022-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Pseudoxanthoma Elasticum – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Pseudoxanthoma Elasticum- Market Insights, Epidemiology, and Market Forec…
Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.
Global In-line UV-Vis Spectroscopy Market Research Report (2021 to 2027) – by Application, End-user and Region – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “In-line UV-Vis Spectroscopy Market Research Report by Application, by End-User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global In…
Ocular Therapeutix™ to Present at the Cowen 42nd Annual Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
National Vision Holdings, Inc. Announces Participation in the UBS Global Consumer and Retail Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced the Company is scheduled to participate in a fireside chat at the UBS Global Consumer and Retail Conference on Thursday, March 10, 2022, at 3:00 p.m. Eastern Tim…
OPTRACT方法：人類捐贈者角膜高效運輸重大成果；未來太空時代零重力細胞儲存庫可用於抗老化研究——日本科學家的策略構想
東京–(BUSINESS WIRE)–(美國商業資訊)–日本科學家開發出更有效率的人類屍體捐贈者角膜運輸方法，可能使捐贈眼睛的供應量增加，為數百萬等待角膜移植以恢復視力的角膜失明病患帶來福音。OPTRACT方法能逆轉細胞老化，從而在醫院和實驗室間的運輸途中更有效地保存人類口腔組織和軟骨。此外，該方法還獲得了在微重力下增強免疫細胞功能的日本專利。研究人員認為，這些成就預示著未來的策略行動，即在沒有重力的空間站上評估星際環境對人類細胞的影響，如果能抵禦與老化有關的損害，可能會產生對抗老化的解決方案…
OPTRACT方法：人类捐献角膜高效运输重大成果；未来太空时代零重力细胞储存库可用于抗衰老研究——日本科学家的战略构想
东京–(BUSINESS WIRE)–(美国商业资讯)–日本科学家开发出一种人类尸体供体角膜的高效运输方法，有望增加供应量，给数百万等待角膜移植以恢复视力的角膜盲症患者带来福音。OPTRACT方法能逆转细胞老化，从而在医院和实验室间的运输途中更好地保存人类口腔组织和软骨。此外，该方法还获得了在微重力下增强免疫细胞功能的日本专利。研究人员认为，这些成就预示着一项未来的战略行动，即在没有重力的空间站上评估星际环境对人类细胞的影响，如果能抵御与衰老有关的损害，可能会产生对抗衰老的解决方案。 再生医学…
Sunvera Group Announces New Partnership with Fite Eye Center
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Group, a portfolio company of Ridgemont, formed a new partnership with Fite Eye Center, advancing their Metro Detroit market presence.
O método OPTRACT: proeza eficiente de transporte de córnea de doador humano e repositório de células futurista em gravidade zero para pesquisa antienvelhecimento e da era espacial; estratégia de cientistas japoneses.
TÓQUIO–(BUSINESS WIRE)–Um método de transporte de córnea de doador de cadáver humano bastante eficiente, desenvolvido por cientistas japoneses, pode aumentar a disponibilidade de olhos doados para milhões de pacientes com cegueira da córnea, à espera…
LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for …
La méthode OPTRACT : Un transport efficace de cornée prélevée sur donneurs humains et le dépôt futuriste de cellules en apesanteur pour la rechercge anti-vieillissement de l’âge de l’aérospatiale ; la stratégie de scientifiques japonaih.
TOKYO–(BUSINESS WIRE)–Une méthode optimisée de transport de cornée prélevée sur des donneurs humains, développée par des scientifiques japonais, pourrait augmenter la disponibilité de dons d’yeux au profit de millions de patients atteints de cécité c…
El método OPTRACT: proeza en el transporte eficiente de la córnea de un donante humano y repositorio de células futuristas en gravedad cero para la investigación antienvejecimiento de la era espacial; estrategia de científicos japoneses.
TOKIO–(BUSINESS WIRE)–Un método de transporte de córnea de donante de cadáver humano muy eficiente, desarrollado por científicos japoneses, puede aumentar la disponibilidad de ojos donados a millones de pacientes con ceguera corneal, que esperan un t…
Riassunto: Il Metodo OPTRACT: Efficace trasporto di cornea umana da donatore e deposito futuristico di cellule a gravità zero per la ricerca sull’età spaziale e anti-invecchiamento; strategia degli scienziati giapponesi.
TOKYO–(BUSINESS WIRE)–Un metodo di trasporto di cadaveri umani molto efficiente, sviluppato da scienziati giapponesi, potrebbe aumentare la disponibilità di occhi donati a milioni di pazienti con cecità corneale, in attesa di un trapianto di cornea c…
Samenvatting: De OPTRACT-methode: efficiënt transport van het hoornvlies van menselijke donoren en futuristische celopslag in gewichtloosheid voor onderzoek naar ruimtetijdperk, anti-veroudering; Strategie door Japanse wetenschappers.
TOKIO–(BUSINESS WIRE)–Een veel efficiënte transportmethode van kadaverdonor-hoornvlies, ontwikkeld door Japanse wetenschappers, kan de beschikbaarheid van gedoneerde ogen vergroten voor miljoenen patiënten met hoornvliesblindheid, in afwachting van h…